Allergen-Specific Immunotherapy

被引：0
作者：
不详
机构：
来源：
MEDICAL LETTER ON DRUGS AND THERAPEUTICS | 2017年 / 59卷 / 1520期
关键词：
CHRONIC SPONTANEOUS URTICARIA; CHRONIC IDIOPATHIC URTICARIA; RANDOMIZED CONTROLLED-TRIAL; ATOPIC-DERMATITIS; FLUTICASONE PROPIONATE; CLINICAL-TRIALS; RHINITIS; MANAGEMENT; EFFICACY; OMALIZUMAB;
D O I：
暂无
中图分类号：
R9 [药学];
学科分类号：
1007 ;
摘要：
引用
收藏
页码：79 / 80
页数：2
相关论文
共 46 条
[1]  
[Anonymous], 2014, MED LETT DRUGS THER, V56, P47
[2]  
[Anonymous], 2017, MED LETT DRUGS THER, V59, P34
[3]  
[Anonymous], 2011, MED LETT DRUGS THER, V53, P19
[4]  
[Anonymous], 2015, MED LETT DRUGS THER, V57, P174
[5]  
[Anonymous], 2017, MED LETT DRUGS THER, V59, pe70
[6]  
[Anonymous], 2013, MED LETT DRUGS THER, V55, P43
[7]  
[Anonymous], 2017, MED LETT DRUGS THER, V59, P64
[8]   A Review of International Recommendations for the Diagnosis and Management of Chronic Urticaria [J].
Beck, Lisa A. ;
Bernstein, Jonathan A. ;
Maurer, Marcus .
ACTA DERMATO-VENEREOLOGICA, 2017, 97 (02) :149-158
[9]  
Blauvelt A, 2017, 75 AM AC DERM AAD AN
[10]  
Castillo M, 2015, COCHRANE DB SYST REV, V6
12345